ACM
Altium Capital Management Portfolio holdings
AUM
$34.4M
1-Year Return
2.5%
This Quarter Return
-0.07%
1 Year Return
-2.5%
3 Year Return
+357.21%
5 Year Return
–
10 Year Return
–
AUM
$375M
AUM Growth
-$56.3M
(-13%)
Cap. Flow
-$44.2M
Cap. Flow
% of AUM
-11.78%
Top 10 Holdings %
Top 10 Hldgs %
22.52%
Holding
176
New
38
Increased
28
Reduced
15
Closed
52
Top Buys
| 1 |
Keros Therapeutics
KROS
|
$4.99M |
| 2 |
Celldex Therapeutics
CLDX
|
$4.96M |
| 3 |
X4 Pharmaceuticals
XFOR
|
$4.26M |
| 4 |
AFMD
Affimed
AFMD
|
$4.11M |
| 5 |
BCYC
Bicycle Therapeutics
BCYC
|
$3.83M |
Top Sells
| 1 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$9.33M |
| 2 |
Palisade Bio
PALI
|
$7.43M |
| 3 |
Crinetics Pharmaceuticals
CRNX
|
$7.16M |
| 4 |
ESSA Pharma
EPIX
|
$6.1M |
| 5 |
electroCore
ECOR
|
$5.95M |
Sector Composition
| 1 | Healthcare | 83.78% |
| 2 | Financials | 5.42% |
| 3 | Technology | 2.08% |
| 4 | Industrials | 1.49% |
| 5 | Communication Services | 1.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
176
Regenxbio
RGNX
$490M
| – | – |
-62,317
| Closed | -$2.42M |
|